MetLife (NYSE:MET) Upgraded at TheStreet

TheStreet upgraded shares of MetLife (NYSE:METGet Rating) from a c+ rating to a b- rating in a research report sent to investors on Thursday morning, TheStreetRatingsTable reports.

Several other equities research analysts have also recently issued reports on the stock. JPMorgan Chase & Co. decreased their price objective on shares of MetLife from $75.00 to $74.00 in a research report on Monday, July 11th. Evercore ISI raised their price target on MetLife to $81.00 in a research note on Tuesday, August 9th. Wolfe Research upgraded MetLife from a market perform rating to an outperform rating and raised their price target for the company from $70.00 to $74.00 in a research note on Wednesday, June 22nd. Credit Suisse Group raised their price target on MetLife from $68.00 to $77.00 and gave the company an outperform rating in a research note on Monday, August 22nd. Finally, Barclays set a $75.00 price target on MetLife in a research note on Tuesday, July 19th. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from, the company presently has an average rating of Moderate Buy and a consensus target price of $76.92.

MetLife Price Performance

Shares of MET stock opened at $65.08 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.13 and a quick ratio of 0.13. The firm’s 50-day moving average is $64.26 and its two-hundred day moving average is $65.58. MetLife has a 12 month low of $57.05 and a 12 month high of $73.18. The company has a market capitalization of $52.92 billion, a PE ratio of 16.19, a price-to-earnings-growth ratio of 0.49 and a beta of 1.05.

MetLife Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Tuesday, August 9th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.07%. The ex-dividend date of this dividend was Monday, August 8th. MetLife’s dividend payout ratio (DPR) is 49.75%.

Insider Transactions at MetLife

In related news, EVP Steven J. Goulart sold 4,060 shares of MetLife stock in a transaction that occurred on Friday, August 19th. The stock was sold at an average price of $67.60, for a total transaction of $274,456.00. Following the completion of the transaction, the executive vice president now directly owns 55,299 shares in the company, valued at approximately $3,738,212.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.26% of the company’s stock.

Institutional Investors Weigh In On MetLife

A number of institutional investors have recently bought and sold shares of MET. Private Trust Co. NA increased its position in shares of MetLife by 49.3% in the second quarter. Private Trust Co. NA now owns 8,245 shares of the financial services provider’s stock worth $518,000 after acquiring an additional 2,721 shares in the last quarter. Brown Advisory Inc. boosted its holdings in MetLife by 1.9% in the 2nd quarter. Brown Advisory Inc. now owns 10,053 shares of the financial services provider’s stock worth $631,000 after acquiring an additional 192 shares during the period. B. Riley Wealth Management Inc. purchased a new position in shares of MetLife in the second quarter valued at $24,983,000. Amundi increased its stake in MetLife by 12.3% during the 2nd quarter. Amundi now owns 1,538,477 shares of the financial services provider’s stock worth $89,092,000 after buying an additional 168,594 shares during the period. Finally, Raleigh Capital Management Inc. grew its stake in shares of MetLife by 7.9% during the second quarter. Raleigh Capital Management Inc. now owns 9,775 shares of the financial services provider’s stock valued at $614,000 after acquiring an additional 715 shares in the last quarter. 86.53% of the stock is currently owned by hedge funds and other institutional investors.

MetLife Company Profile

(Get Rating)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with's FREE daily email newsletter.